Hi Terroni2105.
Both you and Branded have put up a very good question.
I am not sure if he is required under the transition period to follow the Directors reporting requirements on share sales.. I would imagine if he is no longer a director or the CEO in an official capacity he would not be required but a search of ASX rules/regs should answer these questions.
Maybe FF as a Lawyer can comment about this question perhaps?
Yak52
- Forums
- ASX - By Stock
- BRN
- 2021 BRN Discussion
2021 BRN Discussion, page-2094
-
- There are more pages in this discussion • 31,487 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BRN (ASX) to my watchlist
|
|||||
Last
19.8¢ |
Change
0.003(1.28%) |
Mkt cap ! $366.5M |
Open | High | Low | Value | Volume |
19.5¢ | 20.0¢ | 19.5¢ | $182.6K | 928.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
82 | 1751260 | 19.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.0¢ | 643820 | 25 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
82 | 1774289 | 0.195 |
62 | 1667098 | 0.190 |
34 | 1769254 | 0.185 |
51 | 1549834 | 0.180 |
19 | 618862 | 0.175 |
Price($) | Vol. | No. |
---|---|---|
0.200 | 556703 | 22 |
0.205 | 992584 | 18 |
0.210 | 1490483 | 27 |
0.215 | 449851 | 21 |
0.220 | 678461 | 24 |
Last trade - 11.07am 16/07/2024 (20 minute delay) ? |
Featured News
BRN (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online